ABCA3: Biosynthesis, Trafficking, and Cellular Responses in Health and Disease
ABCA3:健康和疾病中的生物合成、贩运和细胞反应
基本信息
- 批准号:7841106
- 负责人:
- 金额:$ 25.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:A549ABCA3 geneATP-Binding Cassette TransportersAdultAlanineAlveolarAmino Acid SequenceAmino AcidsAnabolismAntibodiesApoptoticAttentionBindingBiochemicalBiological AssayCell Death Signaling ProcessCell LineCell membraneCell surfaceCell-Free SystemCellsCharacteristicsChemicalsChildChimeric ProteinsChloride IonChloridesCholesterolCoupledCystic FibrosisCytosolDataDefectDiseaseDistalDsRedEpithelialEpithelial CellsEpitopesEvaluationExhibitsFunctional disorderGenesGolgi ApparatusHealthHomeostasisHumanIn VitroInfantIntegral Membrane ProteinInterstitial Lung DiseasesKnowledgeLeftLinkLipidsLungLung diseasesMediatingMembraneMetabolismMitochondriaMolecularMolecular ChaperonesMutagenesisMutationN,N&apos-bis(4-azidobenzoyl)cystineN-terminalNeonatalNewborn InfantNewborn Respiratory Distress SyndromeOrganellesPathogenesisPathway interactionsPeptidesPhenotypePhospholipidsProcessProteasome InhibitionProtein IsoformsProteinsPublishingPulmonary SurfactantsPumpQuality ControlReportingRoleSagittariaScanningSequence AnalysisSideSignal PathwaySignal TransductionSiteSorting - Cell MovementSphingomyelinsStressStructural ModelsSystemTechniquesTestingTherapeutic InterventionTimeTransgenic MiceTransmembrane DomainWalkersalveolar lamellar bodyalveolar type II cellbasecell injuryfunctional restorationglycosylationhydropathyin vivoinsightlipid transportmathematical algorithmmembermutantpreventprotein foldingprotein misfoldingprotein transportrespiratory distress syndromeresponsesurfactant deficiencytrafficking
项目摘要
DESCRIPTION (provided by applicant): The ATP-binding cassette transporter ABCA3 is a member of the ABC superfamily of transporters that function in the translocation of substrates across cell membranes. Predominantly localized in the limiting membrane of the lamellar bodies of lung alveolar type II cells, ABCA3 is believed to function as a lipid and phospholipid transporter. Recently, ABCA3 has received considerable attention because mutations in the gene are associated with various lung disorders including fatal surfactant deficiency and respiratory distress syndrome (RDS) in newborns and interstitial lung disease (ILD) in older children and adults. While many of the studies thus far have focused primarily on the functional aspects of ABCA3 as a transporter, the cellular responses and consequences in cellular and pulmonary homeostasis as a result of expressing mutant isoforms of ABCA3 are largely undefined. The overall objective of this project is to use a reductionist approach aimed at understanding the molecular mechanisms underlying ABCA3 biosynthesis, and to elucidate the consequences of expression of mutant isoforms of ABCA3 proteins associated with RDS and ILD. Specific Aim 1 will test the hypothesis that the N-terminal domain of ABCA3 is comprised of a short 21 amino acid sequence that harbors signal motifs for insertion of the nascent protein into the ER membrane and for targeting of the protein to post-Golgi distal compartments and the cell surface. Using well established in vitro systems including cell free systems, two epithelial cell lines, human alveolar type II cells, and various molecular and biochemical techniques, we will experimentally elucidate the transmembrane topology and functional motifs of the N-terminal domain of the ABCA3 transporter. In Specific Aim 2, we will investigate cellular responses and molecular mechanisms underlying protein dysfunction and cell injury caused by the expression of misfolded mutant isoforms of ABCA3 using both in vitro studies and in vivo mouse transgenic strategies. We will extend the in vitro studies to include the evaluation of chemical chaperones. These chaperones have the potential to prevent or ameliorate cellular damage caused by promoting proper protein folding and trafficking and by restoring function of the mutant transporter. PROJECT NARRATIVE: In recent times, a considerable attention has been given to the ABCA3 transporter because mutation in the gene is believed to cause various lung diseases. We are taking logical steps to understand the mechanisms underlying the cause of these diseases by focusing on two major aspects of the ABCA3 transporter that have been largely undefined. These include: 1) In vitro examination of ABCA3 protein make up in terms of its targeting motifs and N-terminal domain topology; and 2) In vitro and in vivo elucidation of cellular response as well as effects on cellular homeostasis in response to the expression of its mutant isoforms. We believe the knowledge gained from this project will have a broad application not only toward a better understanding of lung pathogenesis but will offer insights for targeted therapeutic intervention.
描述(申请人提供):三磷酸腺苷结合盒转运体ABCA3是ABC超家族转运体的成员,其功能是底物跨细胞膜的转运。ABCA3主要定位于肺泡II型细胞板层小体的限制膜,被认为是一种脂类和磷脂转运蛋白。最近,由于ABCA3基因的突变与多种肺部疾病有关,包括新生儿的致死性表面活性物质缺乏和呼吸窘迫综合征(RDS),以及年龄较大的儿童和成人的间质性肺疾病(ILD),因此ABCA3受到了相当大的关注。虽然到目前为止,许多研究主要集中在ABCA3作为转运体的功能方面,但由于表达突变的ABCA3亚型,在细胞和肺内稳态中的细胞反应和后果在很大程度上是未知的。本项目的总体目标是使用一种简化论的方法,旨在了解ABCA3生物合成的分子机制,并阐明与RDS和ILD相关的ABCA3蛋白突变异构体表达的后果。具体目标1将检验ABCA3的N-末端结构域由一个短的21个氨基酸组成的假设,该序列含有信号基序,用于将新生蛋白插入内质网膜,并将蛋白靶向高尔基体后远端隔室和细胞表面。利用成熟的体外系统,包括无细胞系统、两个上皮细胞系、人肺泡II型细胞,以及各种分子和生化技术,我们将实验地阐明ABCA3转运蛋白N-末端结构域的跨膜拓扑结构和功能基序。在特定的目标2中,我们将使用体外研究和体内小鼠转基因策略来研究错误折叠的ABCA3突变异构体的表达导致的蛋白质功能障碍和细胞损伤的细胞反应和分子机制。我们将扩大体外研究,包括对化学伴侣的评估。这些分子伴侣有可能通过促进适当的蛋白质折叠和运输以及通过恢复突变转运体的功能来防止或改善细胞损伤。项目简介:最近,ABCA3转运蛋白受到了相当大的关注,因为该基因的突变被认为会导致各种肺部疾病。我们正在采取合乎逻辑的步骤,通过关注ABCA3转运体的两个主要方面来了解这些疾病的潜在机制,这两个方面在很大程度上还没有确定。这些包括:1)体外检测ABCA3蛋白的靶向基序和N-末端结构域拓扑结构;2)在体外和体内阐明细胞响应以及对其突变异构体表达的细胞动态平衡的影响。我们相信,从这个项目中获得的知识不仅将被广泛应用于更好地了解肺部的发病机制,而且将为有针对性的治疗干预提供见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Surafel Mulugeta其他文献
Surafel Mulugeta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Surafel Mulugeta', 18)}}的其他基金
The Biology of the ABCA3 Lipid Transporter in Health and Disease
ABCA3 脂质转运蛋白在健康和疾病中的生物学
- 批准号:
9476314 - 财政年份:2016
- 资助金额:
$ 25.5万 - 项目类别:
The Biology of the ABCA3 Lipid Transporter in Health and Disease
ABCA3 脂质转运蛋白在健康和疾病中的生物学
- 批准号:
9106971 - 财政年份:2016
- 资助金额:
$ 25.5万 - 项目类别:
ABCA3: Biosynthesis, Trafficking, and Cellular Responses in Health and Disease
ABCA3:健康和疾病中的生物合成、贩运和细胞反应
- 批准号:
8041060 - 财政年份:2008
- 资助金额:
$ 25.5万 - 项目类别:
ABCA3: Biosynthesis, Trafficking, and Cellular Responses in Health and Disease
ABCA3:健康和疾病中的生物合成、贩运和细胞反应
- 批准号:
7579053 - 财政年份:2008
- 资助金额:
$ 25.5万 - 项目类别:
ABCA3: Biosynthesis, Trafficking, and Cellular Responses in Health and Disease
ABCA3:健康和疾病中的生物合成、贩运和细胞反应
- 批准号:
7799794 - 财政年份:2008
- 资助金额:
$ 25.5万 - 项目类别:
ABCA3: Biosynthesis, Trafficking, and Cellular Responses in Health and Disease
ABCA3:健康和疾病中的生物合成、贩运和细胞反应
- 批准号:
8238353 - 财政年份:2008
- 资助金额:
$ 25.5万 - 项目类别:
相似海外基金
Interstitial lung diseases (ILD) due to disturbed processing and function of the lipid transporter ABCA3 as a result of mutations in the ABCA3 gene
由于 ABCA3 基因突变,脂质转运蛋白 ABCA3 的加工和功能受到干扰,导致间质性肺疾病 (ILD)
- 批准号:
226491218 - 财政年份:2012
- 资助金额:
$ 25.5万 - 项目类别:
Research Grants














{{item.name}}会员




